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Abstract 
Background: Cancer patients with advanced disease are confronted with increasingly 
complex life-prolonging/symptom-relieving treatment decisions. Being informed of 
treatment benefits and risks is important, but information provision might be suboptimal. 
Objective: To assess the extent to which patients with incurable cancer feel informed 
about benefits and risks of possible treatments, and whether this relates to their self-
perceived receipt of person-centered care. 
Methods: Patients with incurable cancer (N = 212) reported the degree to which they felt 
informed about treatment benefits/risks. Person-centered care was operationalized as 
“feeling involved in care” and “feeling that preferences were taken into account”. 
(Logistic) regression analyses assessed the relationship between feeling informed and 
receiving person-centered care, exploring moderating influences of background 
characteristics. 
Results: Two-thirds (66%) of patients felt incompletely informed about treatment 
benefits/risks. Two-thirds (65%) of patients felt that they were always involved in their 
care, and 60% felt their preferences were taken into account by all providers. If patients 
felt completely informed, they also felt they received more person-centered care (p = < 
0.01). Seventy six percent and 81% of completely informed versus 58% and 50% of 
incompletely informed patients felt that they were, respectively, always involved and 
that preferences were taken into account by all providers. Background characteristics did 
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not moderate these relationships, but influenced perceptions of received information 
and person-centered care. 
Conclusions: Complete information provision about treatment benefits and risks is, 
according to patients, not commonplace. Yet such information is related to receiving 
person-centered care. More research into what specific information is preferred, 
provided, and remembered is warranted, to achieve optimal person-centered care. 
Introduction 
Cancer patients are confronted with increasingly complex treatment options and decisions, also in the 
extending phase of a life-limiting disease.1,2 Treatments may focus either on life prolongation, 
accepting the risk of adverse effects, or on symptom relief (palliation). Being informed of potential 
positive and detrimental treatment consequences is important in advanced illness, where treatment 
decisions are made in a context of limited time and prevalent symptom burden.3,4 
While there is evidence that incurably ill cancer patients are not always aware of and informed of 
treatment benefits and risks, patient's own perception of the extent to which they feel informed is still 
unexplored. For example, it is common for patients to hold unrealistic and sometimes inconsistent 
expectations of treatment benefit.5–7 In one study, 68% of patients believed that treatment could 
erase their cancer, but only 55% believed their disease was curable, indicating that even patients with 
accurate disease insight might hold inaccurate beliefs about treatment benefits.6 A lack of open 
communication from clinicians might contribute to these findings. Observational studies have found a 
lack of open communication about aims, options, and side effects of treatments in advanced illness.8–
10 However, insight into the extent to which people with incurable cancers themselves feel informed 
about potential benefits and risks of treatment options is largely missing. 
It is moreover unclear whether patients who feel better informed about treatment benefits and risks 
also experience their care as more person centered, that is, that care is respectful of and responsive to 
their preferences.11 Person-centered care to optimize patients' quality of life lies at the heart of high-
quality palliative care.12,13 Focusing on terminal care, there is evidence that early discussion of end-of-
life care preferences can result in receipt of terminal care more aligned to patients' preferences.14 This 
is an important finding, as patients' often continue to receive anticancer treatment when their disease 
progresses15–18 increasing the risk of negative outcomes such as (emergency) hospital admissions,16 
intensive medical interventions at the end of life,17 and impaired quality of death.17,19 Greater insight 
into whether information provision about potential benefits and risks of treatments is associated with 
patients' perception of receiving person-centered care preceding the terminal phase is vital. 
Therefore this study had two aims: first, to determine the extent to which incurably ill cancer patients 
feel that they have been informed about the benefits and risks of treatment options. Second, to 
determine the relationship between feeling informed and patient perception of having received 
person-centered care. 
Methods 
Study design 
Cross-sectional analysis of an existing set of questionnaire data, obtained in the evaluation study of 
the Dutch National Quality Improvement Program for Palliative Care (2012–2016).20 The Evaluation 
Program was assessed and approved by the Ethics Committee of the University Medical Center in 
Leiden, the Netherlands (P13.03/NV/nv). 
Participants 
The patient inclusion criteria for the evaluation study were as follows: life expectancy <6 months 
(assessed by the surprise question21) and/or who underwent palliative treatment, understood Dutch, 
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were physically and mentally capable to respond to questionnaires, and had a >1 week care 
relationship. Health care professionals participating in the Evaluation Program collected contact details 
of patients meeting these criteria over a one month period. Patients received a questionnaire by post; 
data were collected from institutionalized patients through an interview. For this analysis only data 
from cancer patients were included (N = 212). 
Measures 
Several items of the validated questionnaire Consumer Quality Index Palliative care (patient version)22 
were analyzed for this article. 
Received information 
The degree to which patients felt that they had received information about benefits and risks/side 
effects of different treatment options was assessed (answer categories “no, not at all”, “a bit”, 
“mostly”, “yes completely”). 
Receipt of person-centered care 
The degree to which patients felt that they had received person-centered care was assessed with two 
items, assessing the extent to which patients felt:  
(i) Involved in decisions about the care they received (answer categories: “never”, “sometimes”, 
“most of the time”, “always”) 
(ii) Care providers took their personal preferences/wishes into account (answer categories: 
“none”, “some”, “most”, “all”). 
Background characteristics that may influence communication preferences or experiences in advanced 
illness were assessed; age,23,24 gender,24–26 and education.23,24 
Statistical analysis 
Analysis was conducted in four stages. First, descriptive statistics was used to assess whether patients 
felt they had received information (dichotomizing answer options into “completely” [“yes completely”] 
and “incompletely” [“no, not at all”, “a bit”, and “mostly”]) and felt they had received person-centered 
care. Second, (logistic) regression analyses determined the influence of background characteristics 
(age, gender, and education) on whether patients felt completely informed and felt they had received 
person-centered care. Third, regression analyses assessed the relationship between feeling informed 
(completely/incompletely) and receiving person-centered care. A sensitivity analysis was performed, 
using logistic regression with alternative dichotomization of the responses into “completely” (“yes 
completely” and “mostly”) and “incompletely” (“no, not at all” and “a bit”) 
Fourth, the moderating effects of background characteristics found to be significant in step 2 on the 
relationship between feeling informed and receiving person-centered care were assessed. Interaction 
effects between background characteristics and feeling informed (completely/incompletely) were 
created, and regression analyses were performed. All analyses were conducted using Stata 14 with 
two-sided significance testing at p ≤ 0.05. Missing data were not imputed. 
Results 
Background characteristics of patients are shown in Table 1. 
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[table 1] 
Feeling informed 
One-third (33%) of patients felt completely informed about benefits and risks/side effects of available 
treatment options, 38% felt mostly informed, 14% felt a bit informed, and 14% felt not informed at all 
(Table 2). 
Female (p = 0.07; OR = 0.57, 95% CI: 0.31–1.04, tendency) and higher educated (p = 0.03; OR = 0.70, 
95% CI: 0.51–0.96) patients felt less completely informed (Fig. 1). Age did not influence the perception 
of feeling completely informed (p = 0.14; β = −0.02, 95% CI: −0.04 to 0.01). 
[figure 1][figure 2] 
Person-centered care 
Two-thirds (65%) of patients felt that they were always involved in the care they received, 28% most of 
the time, 5% sometimes, and 1% felt that they were never involved (Table 2). Higher educated 
patients tended to feel less involved (p = 0.08; β = −0.08, 95% CI: −0.17 to 0.01). Neither gender 
(p = 0.71; β = −0.04, 95% CI: −0.22 to 0.15) nor age (p = 0.15; β = −0.01, 95% CI: −0.01 to 0.00) 
influenced perceived involvement in care received (gender and education displayed in Fig. 2). 
Sixty percent of patients felt that their personal preferences were taken into account by all providers, 
32% by most, 8% by some (Table 2). Older patients tended to feel that their preferences were taken 
less into account (p = 0.08; β = −0.01, 95% CI: −0.01 to 0.00, tendency). Neither gender (p = 0.31; 
β = −0.09, 95% CI: −0.27 to 0.09), nor education (p = 0.17; β = −0.06, 95% CI: −0.15 to 0.03) influenced 
the perception that personal preferences were taken into account (gender and education displayed in 
Fig. 3). 
[figure 3][figure 4] 
Association between feeling informed and receiving person-centered care 
Patients who felt completely informed about treatment benefits and risks also felt more involved in 
their care (p = 0.01; β = 0.29, 95% CI: 0.08–0.49) and that their preferences were taken into account 
(p < 0.01; β = 0.42, 95% CI: 0.23–0.60). More specifically, as illustrated in Figure 4a and b, 76% of the 
patients who felt completely informed also felt that they were always involved in their care, compared 
to 58% of patients who felt incompletely informed. Moreover, 81% of patients who felt completely 
informed stated that their preferences were taken into account by all providers, compared to 50% of 
the patients who felt incompletely informed. 
The sensitivity analysis found that the relationship between feeling informed and feeling involved in 
care (p < 0.01; β = 0.36, 95% CI: 0.15–0.57) and feeling that preferences were taken into account 
(p < 0.01; β = 0.45, 95% CI: 0.26–0.65) remained significant, when an alternative dichotomization of the 
variables was used. 
Moderating effects of background characteristics 
The moderating effect of education on the relationship between feeling informed and feeling involved 
was insignificant (p = 0.34; β = 0.10, 95% CI: −0.10 to 0.30). The moderating effect of age on the 
relationship between feeling informed and feeling that preferences were taken into account was also 
insignificant (p = 0.24; β = −0.01, 95% CI: −0.02 to 0.01). 
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Discussion 
In this survey of Dutch cancer patients with advanced disease, two-thirds of patients felt incompletely 
informed about treatment benefits and risks. When patients did feel completely informed, they also 
felt more involved in their received care and that their preferences were better taken into account. 
Our study adds to the evidence that open communication in advanced cancer is not always achieved, 
even though it is increasingly recognized as important.27 Most patients in our study felt incompletely 
informed about treatment benefits and risks. This corroborates observational studies which found that 
information about an illness being incurable is not mentioned or mentioned only briefly in 47% of 
consultations, while side effect information is omitted in 22–93% of consultations8 (depending on 
specific side effect). When treatment information is discussed, this is mostly done in general terms.9 
Previous Dutch studies found that incurably ill (cancer) patients perceive the provision of information 
about treatment benefits and risks as important28 and in need of improvement.22 Moreover, 95% of 
advanced cancer patients in a recent study opted to receive information about possible adverse 
effects of second-line chemotherapy.29 Taken together, these findings highlight the fact that while 
most patients want to be extensively informed about benefits and risks of treatment, this seems not 
consistently done and is not being experienced as such. 
This is problematic, given our finding that being well-informed is associated with perceived receipt of 
person-centered care. Our results provide further evidence for the link between improved 
communication and improved patient outcomes14,19 and support recent ASCO guidance stressing the 
importance of discussing treatment benefits and risks.27 Being well-informed is a prerequisite for 
making well-informed treatment decisions.30 Seriously ill patients who hold unrealistic beliefs about 
treatment benefit, for example, who are convinced chemotherapy will prolong life31 or face a 1% 
chance for cure,32 may be inclined to accept all side effects. It should be noted that in this study, we 
did not assess the specific decisions that were being made. However, in the advanced phase of a 
disease, care plans are appropriate if consistent with patient preferences.12 To achieve care that takes 
preferences into account, appropriate information provision about treatment benefits and risks (if 
preferred by patients) seems crucial. 
While the positive association between feeling informed and perceived receipt of person-centered 
care was evident for all patients, background characteristics did influence feelings of received 
information and care. Higher educated23,24 and female24 patients tend to have high information needs, 
explaining our findings that they were less likely to feel completely informed. The communication 
barriers which older patients can experience due to functional and cognitive decline and 
multimorbidity33 might contribute to the finding that fewer older people perceived that their 
preferences had been taken into account by all. 
These results beg the question how can clinicians best inform patients about treatment benefits and 
risks, to achieve optimal person-centered care? Although we did not assess which information was 
conveyed or preferred—and information preferences vary between patients23,34,35—the importance of 
lay language, discussing potential adverse effects, acknowledging uncertainty, and checking patients' 
understanding has been highlighted.27,36 Information should be tailored to patients' changing 
preferences,23 and this can be achieved by asking patients about their preferences37 instead of making 
potentially incorrect assumptions.29,38,39 While providing information is important, the risks of 
information provision should also be acknowledged. If patients are informed of40 or expect side effects 
to arise,41,42 this increases their occurrence.43 The optimal balance between full information disclosure 
without increasing the risk of side effects remains to be determined. 
This study has strengths; we used data from a nationwide, relatively large sample of people with 
incurable cancer. It also has limitations. First, we did not know what specific information was provided 
to patients, as consultations were not recorded. Our findings might underestimate what was 
discussed, as patients' information recall is often impaired44–47; only 40–50% of treatment related 
information was recalled in one (experimental) study of advanced cancer consultations.44 We believe, 
Vliet, L.M. van, Veer, A.J.E. de, Raijmakers, N.J.H., Francke, A.L. Is information provision about benefits 
and risks of treatment options associated with receiving person-centered care: a survey among 
incurably ill cancer patients. Journal of Palliative Medicine: 2019, 7, p. 797-803 
 
   
This is a Nivel certified Post Print, more info at nivel.nl 6 
however, that what patients remember, opposed to what is provided, has ultimately most clinical 
relevance and that assessing patients' perceptions is a strength of the study. Second, we used a single 
question to determine whether patients felt informed about both benefits and risks. Previous studies 
found that 65–70% of incurable ill cancer patients felt informed about risks48,49 indicating a potential 
lack in discussing benefits. Third, due to the survey design we can infer relationships, but cannot 
establish causality. Last, it is difficult to establish whether our sample is representative of those with 
advanced cancer in the Netherlands. Participation in the Quality Improvement Program might have led 
to positive perceptions of receiving person-centered care. 
Future studies should consider the relationship between preferred, discussed, and recalled 
information in more detail using both audio-recordings of consultations and patient-reported recall of 
information,46 next to patients' stated preferences. This may provide more guidance for clinicians as to 
which information to provide and how best to do so to optimize patient recall. Further investigation of 
the relationship between the information provided about treatments and the treatment decisions that 
are made is also warranted. Observational studies of consultations can shed light on these questions. 
Moreover, the extent to which incurably ill patients are prone to experience side effects after being 
informed of them needs to be studied, to develop understanding of the balance between full 
information provision while not increasing the occurrence of side effects. 
In conclusion, our results highlight that it is uncommon for patients with advanced cancer to feel that 
they have been fully informed about treatment benefits and risks. When patients feel fully informed, 
this is associated with perceived receipt of person-centered care. In our current era, the growing group 
of patients with advanced cancer is confronted with increasingly complex medical options. It is 
therefore essential that, tailored, information is provided, to support patients in planning for their 
future and making difficult treatment decisions affecting their quality and quantity of life. 
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Tables 
 
Table 1. Background Characteristics 
  M (range) N = 191 
Age 75 (20–98) 
  N (%) 
Gender N = 212 
 Male 92 (43) 
 Female 120 (57) 
Highest education N = 202 
 Low (primary education or less) 49 (24) 
 Intermediate-1 (lower secondary) 83 (41) 
 Intermediate-2 (upper secondary) 34 (17) 
 High (tertiary) 36 (18) 
From the 212 included participants, not all completed all measures. Hence, the number of participants 
per characteristic varies. 
 
 
Table 2. Patient Experiences of Feeling Informed and Receiving Person-Centered Care (i.e., Involved 
in Care Received and Preferences Taken into Account) 
Informed about benefits and risks/side 
effects of treatment options (N = 159) 
Receiving person-centered care 
Involved in care received 
(N = 205) 
Personal preferences taken 
into account (N = 205) 
Answer option N (%) Answer option N (%) Answer option N (%) 
Not at all (no) 28 (14) Never 3 (1) None — 
A bit (no) 27 (14) Sometimes 11 (5) Some 16 (8) 
Mostly (no) 75 (38) Most of the time 58 (28) Most 65 (32) 
Completely (yes) 65 (33) Always 133 (65) All 124 (60) 
From the 212 included participants, not all completed all measures. Hence, the number of participants 
per item varies. 
Due to rounding, not all percentages add up to 100. 
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